Sort
23,748 grants matching “melanoma”
Antigenic determinants on HLA-B7 and-A2
$368,168University Of Virginia Charlottesville · R01 · FY2003 · AI
Re-setting the Endothelial Ceramide Rheostat
$368,132Richard N Kolesnick · Sloan-Kettering Inst Can Research · R01 · FY2014 · CA
Regulation of the Hippo pathway and its role in uveal melanoma
$368,125Kun-Liang Guan · University Of California, San Diego · R01 · FY2013 · EY
Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and Melanoma
$368,121Eva Hernando · New York University School Of Medicine · R01 · FY2012 · CA
Antigenic determinants on HLA-B7 and-A2
$368,113University Of Virginia Charlottesville · R01 · FY2004 · AI
Molecular Pathophysiology of Thyroid Cell Growth
$368,104James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA
Multiple Tumor Antigen-loaded DC Vaccine for Hepatocellular Cancer
$368,058Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA
Antigenic determinants on HLA-B7 and-A2
$368,056University Of Virginia Charlottesville · R01 · FY2005 · AI
CAR T platform to treat solid tumors
$368,052Joana M Murad · Celdara Medical, Llc · R43 · FY2022 · CA
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$368,044Andrew E Aplin · Wistar Institute · P01 · FY2022 · CA
Cancer Center Support Grant
$368,033Benjamin G. Neel · New York University School Of Medicine · P30 · FY2017 · CA
DEVELOPMENT OF CYTOMEGALOVIRUS-BASED VACCINES AGAINST MELANOMA
$368,031University Of Connecticut Health Center · · FY2014 · Department of Defense
Immunotherapy for Skin Cancer Precursors to Prevent Skin Cancer
$368,018Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2019 · AR
Immunomodulation in melanoma therapy
$368,000Noah A Craft · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2009 · CA
Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression
$367,893Richard Heller · Old Dominion University · R01 · FY2016 · CA
Strategies for Receptor inhibition in immunotherapy
$367,811Kenan Christopher Garcia · Stanford University · R01 · FY2023 · CA
Strategies for Receptor inhibition in immunotherapy
$367,811Kenan Christopher Garcia · Stanford University · R01 · FY2022 · CA
Biomaterials-based metabolic rescue of dendritic cells for vaccine design
$367,677Abhinav Acharya · Case Western Reserve University · R01 · FY2024 · AI
Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy
$367,673Caius Gabriel Radu · California Institute Of Technology · U54 · FY2012 · CA
Clinicopathologic and Genetic Profiling through Machine Learning and Natural Language Processing for Precision Lung Cancer Management
$367,647Saeed Hassanpour · Dartmouth College · R01 · FY2022 · CA
Role of p21-activated kinases in thyroid cancer
$367,627Matthew D Ringel · Ohio State University · R01 · FY2022 · CA
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$367,559Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2021 · CA
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$367,559Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2020 · CA
Mouse Resource Core
$367,548Edward A Clark · University Of Washington · U19 · FY2015 · AI
CANCER AND LEUKEMIA GROUP B--RPCI/SUNYAB
$367,544Roswell Park Cancer Institute Corp · U10 · FY2002 · CA